Search research articles
Contact Us
Filters
Showing results (531-540 of 546) with videos related to
Page
of 55
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Marco Öchsner, Matthias Brendel, Nicolai Franzmeier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
Konstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 22, 2021
Feasibility of short imaging protocols for [<sup>18</sup>F]PI-2620 tau-PET in progressive supranuclear palsy
Mengmeng Song, Maximilian Scheifele, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
Leonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study
Sophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
JAMA Neurology
|
November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
Matthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Science Advances
|
October 27, 2023
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
Laura M Bartos, Sabrina V Kirchleitner, Zeynep Ilgin Kolabas, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
Mengmeng Song, Leonie Beyer, Lena Kaiser, et al.
Molecular Psychiatry
|
July 26, 2023
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
Anika Finze, Gloria Biechele, Boris-Stephan Rauchmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 16, 2023
Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
Anna Stockbauer, Leonie Beyer, Maria Huber, et al.
Page
of 55
Search research articles
Search
Showing results (531-540 of 546) with videos related to
Sort By:
Page
of 55
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Marco Öchsner, Matthias Brendel, Nicolai Franzmeier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2022
<sup>18</sup>F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
Konstantin Messerschmidt, Henryk Barthel, Matthias Brendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 22, 2021
Feasibility of short imaging protocols for [<sup>18</sup>F]PI-2620 tau-PET in progressive supranuclear palsy
Mengmeng Song, Maximilian Scheifele, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2020
Early-phase [<sup>18</sup>F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
Leonie Beyer, Alexander Nitschmann, Henryk Barthel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study
Sophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
JAMA Neurology
|
November 9, 2020
Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
Matthias Brendel, Henryk Barthel, Thilo van Eimeren, et al.
Science Advances
|
October 27, 2023
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
Laura M Bartos, Sabrina V Kirchleitner, Zeynep Ilgin Kolabas, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 28, 2021
Binding characteristics of [<sup>18</sup>F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
Mengmeng Song, Leonie Beyer, Lena Kaiser, et al.
Molecular Psychiatry
|
July 26, 2023
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
Anika Finze, Gloria Biechele, Boris-Stephan Rauchmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 16, 2023
Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
Anna Stockbauer, Leonie Beyer, Maria Huber, et al.
Page
of 55